Structure-activity relationships of beta-D-(2S,5R)- and alpha-D-(2S,5S)-1,3-oxathiolanyl nucleosides as potential anti-HIV agents.
L S Jeong, R F Schinazi, J W Beach, H O Kim, K Shanmuganathan, S Nampalli, M W Chun, W K Chung, B G Choi, C K Chu
文献索引:J. Med. Chem. 36(18) , 2627-38, (1993)
全文:HTML全文
摘要
The beta-D-(2S,5R)- and alpha-D-(2S,5S)-1,3-oxathiolanylpyrimidine and -purine nucleosides with natural nucleoside configuration were synthesized and evaluated against HIV-1 in human peripheral blood mononuclear (PBM) cells. The key intermediate 14, which was utilized for the synthesis of various nucleosides, was synthesized from D-mannose or D-galactose. Condensation of the acetate 14 with thymine, uracil, cytosine, and 5-substituted uracils and cytosines gave various pyrimidine nucleosides. The acetate 14 was also condensed with 6-chloropurine and 6-chloro-2-fluoropurine which were converted to various purine nucleosides. In the case of thymine, uracil, and 5-substituted uracil derivatives, most of the compounds did not exhibit any significant anti-HIV activity except 5-fluorouracil (alpha-isomer) derivative 55. Among 5-substituted cytosine analogues, 5-bromocytosine derivative (beta-isomer) 68 was found to be the most potent anti-HIV agent. In the case of purine derivatives, inosine analogue (beta-isomer) 78 was found to be the most potent anti-HIV agent in the 6-substituted purines and 2-amino-6-chloropurine derivative (beta-isomer) 90 showed the most potent activity in the 2,6-disubstituted purine series. The beta-isomers of 6-chloropurine (74), adenine (76), and N6-methyladenine (77) derivatives showed similar potencies against HIV-1, and the corresponding alpha-isomers also exhibited significant anti-HIV activity, although they were generally less potent than the beta-isomers.
相关化合物
相关文献:
2005-10-12
[J. Am. Chem. Soc. 127(40) , 13969-77, (2005)]
2004-10-13
[J. Am. Chem. Soc. 126(40) , 12843-6, (2004)]
1999-10-01
[Nat. Struct. Biol. 6(10) , 913-7, (1999)]
2012-01-01
[Int. Forum Allergy Rhinol. 2(1) , 80-4, (2012)]
2004-06-02
[J. Am. Chem. Soc. 126(21) , 6552-3, (2004)]